CELZ
Income statement / Annual
Last year (2023), Creative Medical Technology Holdings, Inc.'s total revenue was $9,000.00,
a decrease of 89.84% from the previous year.
In 2023, Creative Medical Technology Holdings, Inc.'s net income was -$5.29 M.
See Creative Medical Technology Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$9,000.00
|
$88,600.00
|
$87,754.00
|
$164,500.00
|
$165,500.00
|
$124,400.00
|
$4,800.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$98,184.00 |
$28,491.00 |
$47,949.00 |
$50,596.00 |
$45,499.00 |
$70,375.00 |
$8,000.00 |
$766,072.00 |
$0.00 |
$0.00 |
Gross Profit |
-$89,184.00 |
$60,109.00 |
$39,805.00 |
$113,904.00 |
$120,001.00 |
$54,025.00 |
-$3,200.00 |
-$766,072.00 |
$0.00 |
$0.00 |
Gross Profit Ratio |
-9.91 |
0.68 |
0.45 |
0.69 |
0.73 |
0.43 |
-0.67 |
0 |
0 |
0 |
Research and Development
Expenses |
$1.97 M
|
$6.27 M
|
$109,180.00
|
$0.00
|
$0.00
|
$96,621.00
|
$260,085.00
|
$85,334.00
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.22 M
|
$1.05 M
|
$898,526.00
|
$664,984.00
|
$20,831.00
|
$19,426.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$3.56 M
|
$3.94 M
|
$2.96 M
|
$1.16 M
|
$1.22 M
|
$1.05 M
|
$898,526.00
|
$664,984.00
|
$20,831.00
|
$19,426.00
|
Other Expenses |
$0.00 |
$92,084.00 |
$92,084.00 |
$66,792.00 |
$26,950.00 |
$21,144.00 |
$0.00 |
$9,356.00 |
$0.00 |
$0.00 |
Operating Expenses |
$5.53 M |
$10.30 M |
$3.17 M |
$1.23 M |
$1.25 M |
$1.17 M |
$1.17 M |
$759,674.00 |
$20,831.00 |
$19,426.00 |
Cost And Expenses |
$5.63 M |
$10.33 M |
$3.21 M |
$1.28 M |
$1.30 M |
$1.24 M |
$1.18 M |
$759,674.00 |
$20,831.00 |
$19,426.00 |
Interest Income |
$333,558.00 |
$100,328.00 |
$4.28 M |
$1.23 M |
$1.90 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$0.00 |
-$100,328.00 |
$4.28 M |
$1.23 M |
$1.90 M |
$1.36 M |
$377,587.00 |
$6,398.00 |
$9,930.00 |
$8,586.00 |
Depreciation &
Amortization |
$94,584.00
|
$92,084.00
|
$92,084.00
|
$66,792.00
|
$26,950.00
|
$21,144.00
|
$15,994.00
|
$9,356.00
|
$0.00
|
$0.00
|
EBITDA |
-$5.53 M
|
-$10.05 M
|
-$3.03 M
|
-$1.05 M
|
-$1.10 M
|
-$1.09 M
|
-$1.16 M
|
-$750,318.00
|
-$20,831.00
|
-$19,426.00
|
EBITDA Ratio |
-613.95 |
-113.45 |
-34.57 |
-6.37 |
-6.67 |
-8.79 |
-242.04 |
0 |
0 |
0 |
Operating Income Ratio
|
-624.46
|
-115.62
|
-35.62
|
-6.78
|
-6.83
|
-8.96
|
-245.38
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$333,556.00
|
$100,328.00
|
$22.34 M
|
-$35.21 M
|
-$7.35 M
|
-$11.18 M
|
-$1.10 M
|
$6,398.00
|
-$9,930.00
|
-$8,586.00
|
Income Before Tax |
-$5.29 M |
-$10.14 M |
$19.21 M |
-$36.33 M |
-$8.48 M |
-$13.66 M |
-$2.66 M |
-$766,072.00 |
-$30,761.00 |
-$28,012.00 |
Income Before Tax Ratio
|
-587.4
|
-114.49
|
218.93
|
-220.82
|
-51.26
|
-109.77
|
-553.98
|
0
|
0
|
0
|
Income Tax Expense |
-$4.00 |
-$100,328.00 |
$4.28 M |
$1.23 M |
$1.90 M |
-$11.18 M |
$377,587.00 |
$12,796.00 |
$0.00 |
$0.00 |
Net Income |
-$5.29 M |
-$10.04 M |
$14.93 M |
-$37.55 M |
-$10.38 M |
-$13.66 M |
-$2.66 M |
-$766,072.00 |
-$30,761.00 |
-$28,012.00 |
Net Income Ratio |
-587.4 |
-113.36 |
170.17 |
-228.3 |
-62.71 |
-109.77 |
-553.98 |
0 |
0 |
0 |
EPS |
-3.76 |
-9.19 |
57.32 |
-648.1 |
-5017.67 |
-11351.33 |
-17379.79 |
-5471.94 |
-1281.71 |
-1167.17 |
EPS Diluted |
-3.76 |
-9.19 |
45.97 |
-648.1 |
-5017.67 |
-11351.33 |
-17379.79 |
-5471.94 |
-1281.71 |
-1167.17 |
Weighted Average Shares
Out |
$1.41 M
|
$1.09 M
|
$260,505.00
|
$57,946.00
|
$2,068.53
|
$1,203.00
|
$153.00
|
$140.00
|
$24.00
|
$24.00
|
Weighted Average Shares
Out Diluted |
$1.41 M
|
$1.09 M
|
$324,861.00
|
$57,946.00
|
$2,068.53
|
$1,203.00
|
$153.00
|
$140.00
|
$24.00
|
$24.00
|
Link |
|
|
|
|
|
|
|
|
|
|